Hyaluronic acid in ankle osteoarthritis: Why evidence of efficacy is still lacking?

Clinical and Experimental Rheumatology

Volumn 30, Issue 2, 2012, Pages 277-281

  Abate, Michele ^a   Schiavone, Cosima ^b   Salini, Vincenzo ^c  

^a Department of Neuroscience and Imaging   (Italy)

^b Department of Medicine and Sciences of Aging   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Ankle; Hyaluronic acid; Imaging guidance; Osteoarthritis; Viscosupplementation

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 1BETA; STROMELYSIN;

ANALGESIC ACTIVITY; ANKLE OSTEOARTHRITIS; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HUMAN; JOINT FUNCTION; NONHUMAN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANGE OF MOTION; REVIEW; VISCOSUPPLEMENTATION;

ANIMALS; ANKLE JOINT; BIOMECHANICS; EVIDENCE-BASED MEDICINE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS; TREATMENT OUTCOME; VISCOSUPPLEMENTATION; VISCOSUPPLEMENTS;

EID: 84863762234     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. FELSON DT, LAWRENCE RC, DIEPPE PA et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000; 133: 635-46.
2. ALTMAN R, ALARCON G, APPELROUTH D et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 505-14.
3. RASHAD S, REVELL P, HEMINGWAY A, LOW F, RAINSFORD K, WALKER F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989; 2: 519-22.
4. DINGLE JT: The effects of NSAID on the matrix of human articular cartilages. Z Rheumatol 1999; 58: 125-9.
5. National Collaborating Centre For Chronic Conditions At The Royal College Of Physicians: Osteoarthritis: National clinical guideline for care and management in adults. Royal College of Physicians. 2008.
6. ABATE M, PELOTTI P, DE AMICIS D, DI IORIO A, GALLETTI S, SALINI V: Viscosupplementation with hyaluronic acid in hip osteoarthritis (a review). Ups J Med Sci 2008; 113: 261-77.
7. Salini V, DE AMICIS D, ABATE M, NATALE MA, DI IORIO A: Ultrasound-guided hyaluronic acid injection in carpometacarpal osteoarthritis: short-term results. Int J Immunopathol Pharmacol 2009; 22: 455-60.
8. ABATE M, PULCINI D, DI IORIO A, SCHIAVONE C: Viscosupplementation with intraarticular hyaluronic acid for treatment of osteoarthritis in the elderly. Curr Pharm Des 2010; 16: 631-40.
9. O'REGAN M, MARTINI I, CRESCENZI F, DE LUCA C, LANSING M: Molecular mechanisms and genetics of hyaluronan biosynthesis. Int J Biol Macromol 1994; 16: 283-6.
10. BALAZS EA, DENLINGER JL: Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993; (Suppl. 39): 3-9.
11. BANNURU RR, NATOV NS, DASI UR, SCHMID CH, MCALINDON TE: Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis - meta-analysis. Osteoarthritis Cartilage 2011; 19: 611-9.
12. VAN DEN BEKEROM MP, MYLLE G, RYS B, MULIER M: Viscosupplementation in symptomatic severe hip osteoarthritis: a review of the literature and report on 60 patients. Acta Orthop Belg 2006; 72: 560-8.
13. HERMANSON EN, FERKEL RD: Viscosupplementation for degenerative joint disease of the ankle and foot. Techniques in Foot and Ankle Surgery 2008; 7: 56-63.
14. Marshall KW: Intra-articular hyaluronan therapy. Foot Ankle Clin 2003; 8: 221-32.
15. BALAZS EA: Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Int 2004; 12: 278-89.
16. JÜNI P, REICHENBACH S, TRELLE S et al.; SWISS VISCOSUPPLEMENTATION TRIAL GROUP: Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 2007; 56: 3610-9.
17. KIKUCHI T, YAMADA H, FUJIKAWA K: Effects of high molecular weight hyaluronan on the distribution and movement of proteoglycan around chondrocytes cultured in alginate beads. Osteoarthritis Cartilage 2001; 9: 351-6.
18. SALK R, CHANG T, D'COSTA W, SOOMEKH D, GROGAN K: Viscosupplementation (hyaluronans) in the treatment of ankle osteoarthritis. Clin Podiatr Med Surg 2005; 22: 585-97.
19. RYDELL N, BALAZS EA: Effect of intraarticular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop Relat Res 1971; 80: 25-32.
20. CAKE MA, SMITH MM, YOUNG AA, SMITH SM, GHOSH P, READ RA: Synovial pathology in an ovine model of osteoarthritis: effect of intraarticular hyaluronan (Hyalgan). Clin Exp Rheumatol 2008; 26: 561-7.
21. MORELAND LW: Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003; 5: 54-67.
22. GOMIS A, MIRALLES A, SCHMIDT RF, BELMONTE C: Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application. Pain 2007; 130: 126-36.
23. GIGANTE A, CALLEGARI L: The role of intraarticular hyaluronan (Sinovial(®)) in the treatment of osteoarthritis. Rheumatol Int 2011; 31: 427-44.
24. HULMES DJ, MARSDEN ME, STRACHAN RK, HARVEY RE, MCINNES N, GARDNER DL: Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content. Osteoarthritis Cartilage 2004; 12: 232-8.
25. YATES AC, STEWART AA, BYRON CR, PONDENIS HC, KAUFMANN KM, CONSTABLE PD: Effects of sodium hyaluronate and methylprednisolone acetate on proteoglycan metabolism in equine articular chondrocytes treated with interleukin-1. Am J Vet Res 2006; 67: 1980-6.
26. HOMANDBERG GA, UMMADI V, KANG H: Hyaluronan enhances cartilage repair through low grade tissue remodeling involving cytokines and matrix metalloproteinases. Inflamm Res 2004; 53: 534-43.
27. TANIMOTO K, YANAGIDA T, TANNE Y et al. Modulation of hyaluronan fragmentation by interleukin-1 beta in synovial membrane cells. Ann Biomed Eng. 2010; 38: 1618-25.
28. GREENBERG DD, STOKER A, KANE S, COCKRELL M, COOK JL: Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthritis Cartilage 2006; 14: 814-22.
29. MEI-DAN O, KISH B, SHABAT S, MASARAWA S, SHTEREN A, MANN G, NYSKA M: Treatment of osteoarthritis of the ankle by intra-articular injections of hyaluronic acid: a prospective study. J Am Podiatr Med Assoc 2010; 100: 93-100.
30. YASUDA T: Comparison of hyaluronan effects among normal, osteoarthritis, and rheumatoid arthritis cartilages stimulated with fibronectin fragment. Biomed Res 2010; 31: 63-9.
31. SALK RS, CHANG TJ, D'COSTA WF, SOOMEKH DJ, GROGAN KA: Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 2006; 88: 295-302.
32. COHEN MM, ALTMAN RD, HOLLSTROM R, HOLLSTROM C, SUN C, GIPSON B: Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int 2008; 29: 657-63.
33. KARATOSUN, V. UNVER B, OZDEN A, OZAY Z, GUNAL I: Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clinical and experimental rheumatology. 2008; 26: 288-94.
34. CARPENTER B, MOTLEY T: The role of viscosupplementation in the ankle using hylan G-F 20. J Foot Ankle Surg 2008; 47: 377-84.
35. SUN SF, CHOU YJ, HSU CW et al.: Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis Cartilage 2006; 14: 867-74.
36. VALIVETI M, REGINATO AJ, FALASCA GF: Viscosupplementation for degenerative joint disease of shoulder and ankle. J Clin Rheumatol 2006; 12: 162-3.
37. LUCIANI D, CADOSSI M, TESEI F, CHIARELLO E, GIANNINI S: Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months' follow-up. Chir Organi Mov 2008; 92: 155-60.
38. WITTEVEEN AG, GIANNINI S, GUIDO G et al.: A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis. Foot Ankle Surg 2008; 14: 145-52.
39. WITTEVEEN AG, SIEREVELT IN, BLANKEVOORT L, KERKHOFFS GM, VAN DIJK CN: Intra-articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot Ankle Surg 2010; 16: 159-63.
40. HANSON EC: Sodium hyaluronate - application in a community practice. Am J Orthop November 1999; 28 (11 Suppl.): 11-2.
41. American College Of Rheumatology Subcommittee On Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and the knee: 2000 update. Arthritis Rheum 2000; 43: 1905-15.
42. Leardini A, O'CONNOR JJ, CATANI F, GIANNINI S: The role of the passive structures in the mobility and stability of the human ankle joint: a literature review. Foot Ankle Int 2000; 21: 602-15.
43. HENDREN L, BEESON P: A review of the differences between normal and osteoarthritis articular cartilage in human knee and ankle joints. Foot (Edinb). 2009; 19: 171-6.
44. COLE AA, KUETTNER KE: Molecular basis for differences between human joints. Cell Mol Life Sci 2002; 59: 19-26.
45. KUETTNER KE, COLE AA: Cartilage degeneration in different human joints. Osteoarthritis Cartilage 2005; 13: 93-103.
46. VAN DIJK CN, REILINGH ML, ZENGERINK M, VAN BERGEN CJ: Osteochondral defects in the ankle: why painful? Knee Surg Sports Traumatol Arthrosc 2010; 18: 570-80
47. WINALSKI CS, ALPARSLAN L: Imaging of articular cartilage injuries of the lower extremity. Semin Musculoskelet Radiol 2008; 12: 283-301.
48. ZHANG Y, JORDAN JM: Epidemiology of osteoarthritis. Clin Geriatr Med 2010; 26: 355-69.
49. SALTZMAN CL, SALAMON ML, BLANCHARD GM et al.: Epidemiology of ankle arthritis: report of a consecutive series of 639 patients from a tertiary orthopaedic center. Iowa Orthop J 2005; 25: 44-6.
50. SMITH GN JR, MICKLER EA, MYERS SL, BRANDT KD Effect of intraarticular hyaluronan injection on synovial fluid hyaluronan in the early stage of canine post-traumatic osteoarthritis. J Rheumatol 2001; 28: 1341-6.
51. AGEL J, COETZEE JC, SANGEORZAN BJ, ROBERTS MM, HANSEN ST JR: Functional limitations of patients with end-stage ankle arthrosis. Foot Ankle Int 2005; 26: 537-9.
52. CUNNINGTON J, MARSHALL N, HIDE G et al. A randomized, double-blind, controlled study of ultrasound-guided corticosteroid injection into the joint of patients with inflammatory arthritis. Arthritis Rheum 2010; 62: 1862-9.
53. WOO SB, WONG TM, CHAN WL, YEN CH, WONG WC, MAK KL: Anatomic variations of neurovascular structures of the ankle in relation to arthroscopic portals: a cadaveric study of Chinese subjects. J Orthop Surg (Hong Kong) 2010; 18: 71-5.
54. MAHEU E, ZAIM M, APPELBOOM T et al. Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial. Clin Exp Rheumatol 2011; 29: 527-35.